BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10779419)

  • 21. Secondary or concomitant neoplasms among adults diagnosed with acute lymphoblastic leukemia and treated according to the LALA-87 and LALA-94 trials.
    Tavernier E; Le QH; de Botton S; Dhédin N; Bulabois CE; Reman O; Vey N; Lhéritier V; Dombret H; Thomas X
    Cancer; 2007 Dec; 110(12):2747-55. PubMed ID: 17963265
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thiopurine methyltransferase genetics is not a major risk factor for secondary malignant neoplasms after treatment of childhood acute lymphoblastic leukemia on Berlin-Frankfurt-Münster protocols.
    Stanulla M; Schaeffeler E; Möricke A; Coulthard SA; Cario G; Schrauder A; Kaatsch P; Dördelmann M; Welte K; Zimmermann M; Reiter A; Eichelbaum M; Riehm H; Schrappe M; Schwab M
    Blood; 2009 Aug; 114(7):1314-8. PubMed ID: 19535798
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative results of two intensive treatment programs for childhood acute lymphoblastic leukemia: The Berlin-Frankfurt-Münster and Dana-Farber Cancer Institute protocols.
    Niemeyer CM; Reiter A; Riehm H; Donnelly M; Gelber RD; Sallan SE
    Ann Oncol; 1991; 2(10):745-9. PubMed ID: 1801880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.
    Möricke A; Zimmermann M; Reiter A; Henze G; Schrauder A; Gadner H; Ludwig WD; Ritter J; Harbott J; Mann G; Klingebiel T; Zintl F; Niemeyer C; Kremens B; Niggli F; Niethammer D; Welte K; Stanulla M; Odenwald E; Riehm H; Schrappe M
    Leukemia; 2010 Feb; 24(2):265-84. PubMed ID: 20010625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Secondary cancers among children with acute lymphoblastic leukaemia treated by the Tokyo Children's Cancer Study Group protocols: a retrospective cohort study.
    Ishida Y; Maeda M; Urayama KY; Kiyotani C; Aoki Y; Kato Y; Goto S; Sakaguchi S; Sugita K; Tokuyama M; Nakadate N; Ishii E; Tsuchida M; Ohara A;
    Br J Haematol; 2014 Jan; 164(1):101-12. PubMed ID: 24116892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
    Cherlow JM; Steinherz PG; Sather HN; Gaynon PS; Grossman NJ; Kersey JH; Johnstone HS; Breneman JC; Trigg ME; Hammond GD
    Int J Radiat Oncol Biol Phys; 1993 Dec; 27(5):1001-9. PubMed ID: 8262820
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second malignancies after treatment of childhood non-Hodgkin lymphoma: a report of the Berlin-Frankfurt-Muenster study group.
    Moser O; Zimmermann M; Meyer U; Klapper W; Oschlies I; Schrappe M; Attarbaschi A; Mann G; Niggli F; Spix C; Kontny U; Klingebiel T; Reiter A; Burkhardt B; Woessmann W
    Haematologica; 2021 May; 106(5):1390-1400. PubMed ID: 32299903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia.
    Conter V; Aricò M; Basso G; Biondi A; Barisone E; Messina C; Parasole R; De Rossi G; Locatelli F; Pession A; Santoro N; Micalizzi C; Citterio M; Rizzari C; Silvestri D; Rondelli R; Lo Nigro L; Ziino O; Testi AM; Masera G; Valsecchi MG;
    Leukemia; 2010 Feb; 24(2):255-64. PubMed ID: 20016536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.
    Schrappe M; Aricò M; Harbott J; Biondi A; Zimmermann M; Conter V; Reiter A; Valsecchi MG; Gadner H; Basso G; Bartram CR; Lampert F; Riehm H; Masera G
    Blood; 1998 Oct; 92(8):2730-41. PubMed ID: 9763557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utility of miR-143/miR-182 levels in prognosis and risk stratification specificity of BFM-treated childhood acute lymphoblastic leukemia.
    Piatopoulou D; Avgeris M; Drakaki I; Marmarinos A; Xagorari M; Baka M; Pourtsidis A; Kossiva L; Gourgiotis D; Scorilas A
    Ann Hematol; 2018 Jul; 97(7):1169-1182. PubMed ID: 29556721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic cerebrospinal fluid examination in children with acute lymphoblastic leukemia: significance of low leukocyte counts with blasts or traumatic lumbar puncture.
    Bürger B; Zimmermann M; Mann G; Kühl J; Löning L; Riehm H; Reiter A; Schrappe M
    J Clin Oncol; 2003 Jan; 21(2):184-8. PubMed ID: 12525508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness of intensified rotational combination chemotherapy for late hematologic relapse of childhood acute lymphoblastic leukemia.
    Rivera GK; Hudson MM; Liu Q; Benaim E; Ribeiro RC; Crist WM; Pui CH
    Blood; 1996 Aug; 88(3):831-7. PubMed ID: 8704238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inferior prognosis of adolescents with acute lymphoblastic leukaemia (ALL) is caused by a higher rate of treatment-related mortality and not an increased relapse rate--a population-based analysis of 25 years of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) Study Group.
    Pichler H; Reismüller B; Steiner M; Dworzak MN; Pötschger U; Urban C; Meister B; Schmitt K; Panzer-Grümayer R; Haas OA; Attarbaschi A; Mann G;
    Br J Haematol; 2013 May; 161(4):556-65. PubMed ID: 23480776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second malignant tumors after elective end of therapy for a first cancer in childhood: a multicenter study in Italy.
    Rosso P; Terracini B; Fears TR; Jankovic M; Fossati Bellani F; Arrighini A; Carli M; Cordero di Montezemolo L; Garrè ML; Guazzelli C
    Int J Cancer; 1994 Nov; 59(4):451-6. PubMed ID: 7960210
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
    Nachman J; Sather HN; Gaynon PS; Lukens JN; Wolff L; Trigg ME
    J Clin Oncol; 1997 Jun; 15(6):2222-30. PubMed ID: 9196134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
    Steinherz PG; Gaynon PS; Breneman JC; Cherlow JM; Grossman NJ; Kersey JH; Johnstone HS; Sather HN; Trigg ME; Uckun FM; Bleyer WA
    Cancer; 1998 Feb; 82(3):600-12. PubMed ID: 9452280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies.
    Putti MC; Rondelli R; Cocito MG; Aricó M; Sainati L; Conter V; Guglielmi C; Cantú-Rajnoldi A; Consolini R; Pession A; Zanesco L; Masera G; Biondi A; Basso G
    Blood; 1998 Aug; 92(3):795-801. PubMed ID: 9680347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years' experience.
    Attarbaschi A; Mann G; Dworzak M; Urban C; Fink FM; Dieckmann K; Riehm H; Gadner H;
    Wien Klin Wochenschr; 2002 Feb; 114(4):148-57. PubMed ID: 12060981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.